Molecular Biomarkers of Bladder Cancer: A Mini-Review

Role of FGFR3 in bladder cancer: Treatment landscape and future challenges

(2023) Claudia Maria Ascione et al.   CANCER TREATMENT REVIEWS

In Situ Constructed Nano‐drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer

(2022) Da-Yong Hou et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Bladder cancer diagnosis with a four-miRNA panel in serum

(2022) Xinji Li et al.   Future Oncology

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs

(2022) Stefan Harsanyi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer

(2021) Jiacheng Wu et al.   OncoTargets and Therapy

Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies

(2021) Michelle Hong et al.   Cancers

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumoral markers in bladder cancer (Review)

(2021) Ovidiu Bratu et al.   Experimental and Therapeutic Medicine

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis

(2021) Chunyu Zhang et al.   Frontiers in Oncology

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy

(2020) Danijel Sikic et al.   Journal of Clinical Medicine

Urinary biomarkers in bladder cancer: A review of the current landscape and future directions

(2020) Kenrick Ng et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Clinical value of microRNA‑198‑5p downregulation in lung adenocarcinoma and its potential pathways

(2019) Shi‑Shuo Wang et al.   Oncology Letters

The forkhead domain hinge-loop plays a pivotal role in DNA binding and transcriptional activity of FOXP2

(2018) Gavin Morris et al.   BIOLOGICAL CHEMISTRY

Bladder Cancer: New Insights into Its Molecular Pathology

(2018) Kentaro Inamura   Cancers

GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator

(2017) Satoshi Inoue et al.   HUMAN PATHOLOGY

Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder

(2017) Jochen Hess et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype

(2017) Sara Lenherr et al.   Genes

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes

(2016) Masayoshi Nagata et al.   DISEASE MARKERS

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours

(2016) Peter A. Humphrey et al.   EUROPEAN UROLOGY

miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling

(2016) Hengbing Wang et al.   Oncology Letters

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications

(2015) Teresa Helsten et al.   CANCER AND METASTASIS REVIEWS

Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis

(2015) Q. Lv et al.   Clinical & Translational Oncology

High co-expression of Sp1 and HER-2 is correlated with poor prognosis of gastric cancer patients

(2015) Weihua Jiang et al.   SURGICAL ONCOLOGY-OXFORD

Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer

(2015) Elin Andersson et al.   PLoS One

Loss of GATA3 in bladder cancer promotes cell migration and invasion

(2014) Yi Li et al.   CANCER BIOLOGY & THERAPY

Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target

(2014) Stephen Safe et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics

(2014) Madaswamy S. Muthu et al.   Theranostics

GATA3

(2013) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Novel Molecular Grading Model: Combination of Ki67 and VEGF in Predicting Tumor Recurrence and Progression in Non-invasive Urothelial Bladder Cancer

(2012) Jun-Xing Chen et al.   Asian Pacific Journal of Cancer Prevention

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

(2012) Hiroshi Miyamoto et al.   BJU INTERNATIONAL

The big picture on nanomedicine: the state of investigational and approved nanomedicine products

(2012) Michael L. Etheridge et al.   Nanomedicine-Nanotechnology Biology and Medicine

Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation

(2012) David J. DeGraff et al.   PLoS One

RNA Interference-Mediated Vascular Endothelial Growth Factor-C Reduction Suppresses Malignant Progression and Enhances Mitomycin C Sensitivity of Bladder Cancer T24 Cells

(2011) Hui-hui Zhang et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Gold nanoparticles generated and stabilized by water soluble curcumin–polymer conjugate: Blood compatibility evaluation and targeted drug delivery onto cancer cells

(2011) S. Manju et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Gata-3 Negatively Regulates the Tumor-Initiating Capacity of Mammary Luminal Progenitor Cells and Targets the Putative Tumor Suppressor Caspase-14

(2011) M.-L. Asselin-Labat et al.   MOLECULAR AND CELLULAR BIOLOGY

MicroRNA Alterations and Associated Aberrant DNA Methylation Patterns across Multiple Sample Types in Oral Squamous Cell Carcinoma

(2011) Erik D. Wiklund et al.   PLoS One

Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing

(2011) Yu-Hua Chen et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Impact of gender on bladder cancer incidence, staging, and prognosis

(2011) Harun Fajkovic et al.   WORLD JOURNAL OF UROLOGY

MicroRNAs and cancer: An overview

(2010) Pedro P. Medina et al.   CELL CYCLE

Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer

(2010) Nuh N. Rahbari et al.   GASTROENTEROLOGY

Cadherin Switching and Bladder Cancer

(2010) Richard T. Bryan et al.   JOURNAL OF UROLOGY

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

(2010) Pedro P. Medina et al.   NATURE

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

p53 expression in patients with advanced urothelial cancer of the urinary bladder

(2009) Shahrokh F. Shariat et al.   BJU INTERNATIONAL

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma

(2008) N. Y. Jiang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH